Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mediterranean diet and nonalcoholic fatty liver disease
Caterina Anania, Francesco Massimo Perla, Francesca Olivero, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 19, pp. 2083-2094
Open Access | Times Cited: 296

Showing 1-25 of 296 citing articles:

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2579
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero‐Gómez, Shira Zelber‐Sagi, Michael I. Trenell
Journal of Hepatology (2017) Vol. 67, Iss. 4, pp. 829-846
Open Access | Times Cited: 1095
ESPEN guideline on clinical nutrition in liver disease
Mathias Plauth, William Bernal, Srinivasan Dasarathy, et al.
Clinical Nutrition (2019) Vol. 38, Iss. 2, pp. 485-521
Open Access | Times Cited: 514
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
Amélio F. Godoy‐Matos, Wellington S. Silva Júnior, Cynthia Melissa Valério
Diabetology & Metabolic Syndrome (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 478
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Daniela Maria Tănase, Evelina Maria Gosav, Claudia Florida Costea, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 396
NAFLD in children: new genes, new diagnostic modalities and new drugs
Valério Nobili, Anna Alisi, Luca Valenti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 9, pp. 517-530
Closed Access | Times Cited: 256
ESPEN practical guideline: Clinical nutrition in liver disease
Stephan C. Bischoff, William Bernal, Srinivasan Dasarathy, et al.
Clinical Nutrition (2020) Vol. 39, Iss. 12, pp. 3533-3562
Open Access | Times Cited: 252
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
Massimiliano Caprio, Marco Infante, Eleonora Moriconi, et al.
Journal of Endocrinological Investigation (2019) Vol. 42, Iss. 11, pp. 1365-1386
Closed Access | Times Cited: 234
The Mediterranean dietary pattern as the diet of choice for non‐alcoholic fatty liver disease: Evidence and plausible mechanisms
Shira Zelber‐Sagi, Federico Salomone, Liat Mlynarsky
Liver International (2017) Vol. 37, Iss. 7, pp. 936-949
Open Access | Times Cited: 229
Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management
Thomas Marjot, Ahmad Moolla, Jeremy Cobbold, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 66-117
Open Access | Times Cited: 191
The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil
P. Ditano-Vázquez, José D. Torres‐Peña, Francisco Galeano‐Valle, et al.
Nutrients (2019) Vol. 11, Iss. 11, pp. 2833-2833
Open Access | Times Cited: 189
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Carolina M. Perdomo, Gema Frühbeck, Javier Escalada
Nutrients (2019) Vol. 11, Iss. 3, pp. 677-677
Open Access | Times Cited: 187
Health Benefits of Mediterranean Diet
Daniela Martini
Nutrients (2019) Vol. 11, Iss. 8, pp. 1802-1802
Open Access | Times Cited: 180
Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management
D. Huang, Jason Behary, Amany Zekry
Internal Medicine Journal (2019) Vol. 50, Iss. 9, pp. 1038-1047
Closed Access | Times Cited: 174
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Claudio Tana, Stefano Ballestri, Fabrizio Ricci, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 17, pp. 3104-3104
Open Access | Times Cited: 172
The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults
Angeliki Papadaki, Eric Nolen‐Doerr, Christos S. Mantzoros
Nutrients (2020) Vol. 12, Iss. 11, pp. 3342-3342
Open Access | Times Cited: 170
Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial
Hua Cai, Yuelan Qin, Zeya Shi, et al.
BMC Gastroenterology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 163
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 135
Diet and exercise in NAFLD/NASH: Beyond the obvious
Georg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International (2021) Vol. 41, Iss. 10, pp. 2249-2268
Open Access | Times Cited: 118
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors
Emir Muzurović, Carol Chiung‐Hui Peng, Matthew J. Belanger, et al.
Hypertension (2022) Vol. 79, Iss. 7, pp. 1319-1326
Closed Access | Times Cited: 84
Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants
Fanny Petermann‐Rocha, Michael D. Wirth, Jirapitcha Boonpor, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 49
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 22
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 22
Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Paweł Rajewski, Jakub Cieściński, Piotr Rajewski, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 217-217
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top